TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 50 filers reported holding TYRA BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,155,739 | -19.1% | 1,028,013 | 0.0% | 0.94% | -10.1% |
| Q2 2023 | $17,507,061 | -23.4% | 1,028,013 | -27.7% | 1.05% | -36.8% |
| Q1 2023 | $22,840,452 | +126.4% | 1,421,310 | +7.1% | 1.65% | +163.8% |
| Q4 2022 | $10,090,254 | -13.5% | 1,327,665 | 0.0% | 0.63% | -30.3% |
| Q3 2022 | $11,670,000 | +18.7% | 1,327,665 | -3.4% | 0.90% | -3.1% |
| Q2 2022 | $9,832,000 | -30.8% | 1,375,065 | +3.6% | 0.93% | -23.4% |
| Q1 2022 | $14,206,000 | – | 1,327,665 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $31,531,000 | 11.23% |
| Nextech Invest Ltd. | 2,518,582 | $18,008,000 | 6.07% |
| Boxer Capital, LLC | 6,448,359 | $46,106,000 | 2.92% |
| TCG Crossover Management, LLC | 896,418 | $6,409,000 | 2.72% |
| Fairmount Funds Management LLC | 1,416,998 | $10,132,000 | 2.32% |
| RA Capital Management | 7,236,454 | $51,741,000 | 1.38% |
| Frazier Life Sciences Management, L.P. | 1,375,065 | $9,832,000 | 0.93% |
| BVF INC/IL | 2,472,327 | $17,677,000 | 0.85% |
| Sio Capital Management, LLC | 152,159 | $1,088,000 | 0.41% |
| Cormorant Asset Management, LP | 743,988 | $5,320,000 | 0.40% |